Effects of plasma from patients with fulminant hepatic failure on function of primary rat hepatocytes in three-dimensional culture

Liver International

Volumn 25, Issue 5, 2005, Pages 1010-1017

  Nagaki, Masahito ^a   Naito, Tomoo ^a   Ohnishi, Hiroo ^a   Akaike, Toshihiro ^b   Muto, Yasutoshi ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Bioartificial liver; Cell differentiation; Cell growth; Spheroid

Indexed keywords

ALBUMIN; AMIDE; COLLAGEN; LACTONE DERIVATIVE; STYRENE DERIVATIVE; UREA;

AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; CELL FUNCTION; CELL SECRETION; CELL SHAPE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOTOXICITY; GLUCONEOGENESIS; HUMAN; LIVER CELL; LIVER CELL CULTURE; LIVER FAILURE; MALE; MONOLAYER CULTURE; NONHUMAN; PLASMA; RAT; SPHEROID CELL;

ALBUMINS; AMINO ACIDS; ANIMALS; CELLS, CULTURED; GLUCONEOGENESIS; HEPATOCYTES; LIVER FAILURE, ACUTE; MALE; PROTEIN BIOSYNTHESIS; RATS; RATS, WISTAR; UREA;

EID: 26044464224     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01127.x     Document Type: Article

References (28)

1. Gill R Q, Sterling R K. Acute liver failure. J Clin Gastroenterol 2001; 33: 191-8.
2. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004; 40: 192-7.
3. Stockmann H B, Zermans J N. Prospects for the temporary treatment of acute liver failure. Eur J Gastroenterol Hepatol 2002; 14: 195-203.
4. Kelly J H, Koussayer T, He D, Chong M G, Shang T A, Whisennand H H, Sussman N L. An improved model of acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 1992; 15: 329-35.
5. Rozga J, Williams F, Ro M - S, Neuzil D F, Giorgid T D, Backfisch G, Moscioni A D, Hakim R, Demetriou A A. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993; 17: 258-65.
6. Jauregui H O, Mullon C J, Trenkler D, Naik S, Santangini H, Press P, Muller T E, Solomon B A. In vivo evaluation of a hollow fiber liver assist device. Hepatology 1995; 21: 460-9.
7. Sielaff T D, Hu M Y, Amiot B, Rollins M D, Rao S, McGiure B, Bloomer J R, Hu W - S, Cerra F B. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 1995; 59: 179-84.
8. Nagaki M, Miki K, Kim Y - I, Ishiyama H, Hirahara I, Takahashi H, Sugiyama A, Muto Y, Moriwaki H. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix. Dig Dis Sci 2001; 46: 1046-56.
9. Ellis A J, Hughes R D, Wendon J A, Dunne J, Langley P G, Kelly J H, Gislason G T, Sussman N L, Williams R. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446-51.
10. Morsiani E, Pazzi P, Puviani A C, Brogli M, Valieri L, Gorini P, Scoletta P, Marangoni E, Ragazzi R, Azzena G, Frazzoli E, Di Luca D, Cassai E, Lombardi G, Cavallari A, Faenza S, Pasetto A, Girardis M, Jovine E, Pinna A D. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs 2002; 25: 192-202.
11. Demetriou A A, Brown R S Jr, Busuttil R W, Fair J, McGuire B M, Rosenthal P, Am Esch J S 2nd, Lerut J, Nyberg S L, Salizzoni M, Fagan E A, de Hemptinne B, Broelsch C E, Muraca M, Salmeron J M, Rabkin J M, Metselaar H J, Pratt D, De La Mata M, McChesney L P, Everson G T, Lavin P T, Stevens A C, Pitkin Z, Solomon B A. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-7.
12. Nagaki M, Shidoji Y, Yamada Y, Sugiyama A, Tanaka M, Akaike T, Ohnishi H, Moriwaki H, Muto Y. Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem Biophys Res Commun 1995; 210: 38-43.
13. Tobe S, Takei Y, Kobayashi K, Akaike T. Receptor-mediated formation of multilayer aggregates of primary cultures adult rat hepatocytes on lactose-substitude polystyrene. Biochem Biophys Res Commun 1992; 184: 225-30.
14. Hughes R D, Yamada H, Gove C D, Williams R. Inhibitors of hepatic DNA synthesis in fulminant hepatic failure. Dig Dis Sci 1991; 36: 816-9.
15. Yamada H, Toda G, Yoshiba M, Hashimoto N, Ikeda Y, Mitsui H, Kurokawa K, Sugata F, Hughes R D, Williams R. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure. Hepatology 1994; 19: 1133-40.
16. Sewell R B, Hughes R D, Poston L, Williams R. Effects of serum from patients with fulminant hepatic failure on leukocyte sodium transport. Clin Sci 1982; 63: 237-42.
17. Newsome P N, Tsiaoussis J, Masson S, Buttery R, Livingston C, Ansell I, Ross J A, Sethi T, Hayes P C, Plevris J N. Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a β1-integrin pathway. Hepatology 2004; 40: 636-45.
18. Seglen P O. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29-83.
19. Kobayashi A, Goto M, Kobayashi K, Akaike T. Receptor-mediated regulation of differentiation and proliferation of hepatocytes by synthetic polymer model of asialoglycoprotein. J Biomater Sci Polym Ed 1994; 6: 325-42.
20. Nagaki M, Kano T, Muto Y, Yamada T, Ohnishi H, Moriwaki H. Effects of intraperitoneal transplantation of microcarrier-attached hepatocytes on D-galactosamine-induced acute liver failure in rats. Gastroenterol Jpn 1990; 25: 78-87.
21. Saavendra Y G, Mateescu M A, Averill-Bates D A, Denizeau F. Polyvinylalcohol three-dimensional matrices for improved long-term dynamic culture of hepatocytes. J Biomed Mater Res 2003; 66: 562-70.
22. Fiegel H C, Havers J, Kneser U, Smith M K, Moeller T, Kluth D, Mooney D J, Rogiers X, Kaufmann P M. Influence of flow conditions and matrix coatings on growth and differentiation of three-dimensionally cultured rat hepatocytes. Tissue Eng 2004; 10: 165-74.
23. Shi Q, Gaylor J D S, Cousins R, Plevris J, Hayes P C, Grant M H. The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs 1998; 22: 1023-30.
24. Haas T, Holloway C J, Osterthun V, Trautschold. Hepatotoxic effects of sera from patients with fulminant hepatitis B on isolated rat hepatocytes in culture. J Clin Chem Clin Biochem 1981; 19: 283-6.
25. Yamashita Y, Shimada M, Tsuji E, Shirabe K, Ijima H, Nakazawa K, Sakiyama R, Fukuda J, Funatsu K, Sugimachi K. High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture in plasma from patients with Fulminant hepatic failure. Cell Transplant 2002; 11: 379-84.
26. Stefanovich P, Matthew H W T, Toner M, Tompkins R G, Yarmush M L. Extracorporeal plasma perfusion of cultured hepatocytes: effect of intermittent perfusion on hepatocyte function and morphology. J Surg Res 1996; 66: 57-63.
27. Gohda E, Tsubouchi H, Nakayama H. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-9.
28. Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, Sugihara J, Tomita E, Muto Y, Daikuhara Y, Hashimoto S. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989; 9: 875-81.